A Study of SHR-4610 Injection in Patients With Advanced Solid Tumors
Clinical trial NCT07231211 · RECRUITING
Trial details
- NCT number
- NCT07231211
- Sponsor
- Shanghai Shengdi Pharmaceutical Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-20
- Primary completion
- 2026-10-01
- Enrollment
- 258
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.